FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2312703485> ?p ?o ?g. }

• W2312703485 endingPage "530" @default.
• W2312703485 startingPage "524" @default.
• W2312703485 abstract "Cisplatin (cis-diamminedichloroplatinum) has been reported to enhance the cell-killing effect of radiation, an effect whose intensity varies with the schedule of administration. We randomly assigned 331 patients with nonmetastatic inoperable non-small-cell lung cancer to one of three treatments: radiotherapy for two weeks (3 Gy given 10 times, in five fractions a week), followed by a three-week rest period and then radiotherapy for two more weeks (2.5 Gy given 10 times, five fractions a week); radiotherapy on the same schedule, combined with 30 mg of cisplatin per square meter of body-surface area, given on the first day of each treatment week; or radiotherapy on the same schedule, combined with 6 mg of cisplatin per square meter, given daily before radiotherapy.Survival was significantly improved in the radiotherapy-daily-cisplatin group as compared with the radiotherapy group (P = 0.009): survival in the radiotherapy-daily-cisplatin group was 54 percent at one year, 26 percent at two years, and 16 percent at three years, as compared with 46 percent, 13 percent, and 2 percent, respectively, in the radiotherapy group. Survival in the radiotherapy-weekly-cisplatin group was intermediate (44 percent, 19 percent, and 13 percent) and not significantly different from survival in either of the other two groups. The survival benefit of daily combined treatment was due to improved control of local disease (P = 0.003). Survival without local recurrence was 59 percent at one year and 31 percent at two years in the radiotherapy-daily-cisplatin group; 42 percent and 30 percent, respectively, in the radiotherapy-weekly-cisplatin group; and 41 percent and 19 percent, respectively, in the radiotherapy group. Cisplatin induced nausea and vomiting in 86 percent of the patients given it weekly and in 78 percent of those given it daily; these effects were severe in 26 percent and 28 percent, respectively.Cisplatin, given daily in combination with the radiotherapy described here to patients with nonmetastatic but inoperable non-small-cell lung cancer, improved rates of survival and control of local disease at the price of substantial side effects." @default.
• W2312703485 created "2016-06-24" @default.
• W2312703485 creator A5009403725 @default.
• W2312703485 creator A5022885422 @default.
• W2312703485 creator A5028164886 @default.
• W2312703485 creator A5040921984 @default.
• W2312703485 creator A5052619645 @default.
• W2312703485 creator A5067054454 @default.
• W2312703485 creator A5072776358 @default.
• W2312703485 creator A5080080048 @default.
• W2312703485 creator A5082310935 @default.
• W2312703485 creator A5089730795 @default.
• W2312703485 date "1992-02-20" @default.
• W2312703485 modified "2023-10-16" @default.
• W2312703485 title "Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer" @default.
• W2312703485 cites W1531055531 @default.
• W2312703485 cites W1978156658 @default.
• W2312703485 cites W1980020949 @default.
• W2312703485 cites W1984674564 @default.
• W2312703485 cites W1995713828 @default.
• W2312703485 cites W1996308010 @default.
• W2312703485 cites W2002261289 @default.
• W2312703485 cites W2026097725 @default.
• W2312703485 cites W2031129917 @default.
• W2312703485 cites W2049055491 @default.
• W2312703485 cites W2051767374 @default.
• W2312703485 cites W2053888668 @default.
• W2312703485 cites W2058606676 @default.
• W2312703485 cites W2064278976 @default.
• W2312703485 cites W2072659822 @default.
• W2312703485 cites W2073879537 @default.
• W2312703485 cites W2082208022 @default.
• W2312703485 cites W2085902464 @default.
• W2312703485 cites W2093039348 @default.
• W2312703485 cites W2094405661 @default.
• W2312703485 cites W2105365583 @default.
• W2312703485 cites W2105737184 @default.
• W2312703485 cites W2116772424 @default.
• W2312703485 cites W2117962338 @default.
• W2312703485 cites W2132130760 @default.
• W2312703485 cites W2159577139 @default.
• W2312703485 cites W2226077283 @default.
• W2312703485 cites W2317448174 @default.
• W2312703485 cites W2327612061 @default.
• W2312703485 cites W2341319633 @default.
• W2312703485 cites W2465127992 @default.
• W2312703485 doi "https://doi.org/10.1056/nejm199202203260805" @default.
• W2312703485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1310160" @default.
• W2312703485 hasPublicationYear "1992" @default.
• W2312703485 type Work @default.
• W2312703485 sameAs 2312703485 @default.
• W2312703485 citedByCount "1226" @default.
• W2312703485 countsByYear W23127034852012 @default.
• W2312703485 countsByYear W23127034852013 @default.
• W2312703485 countsByYear W23127034852014 @default.
• W2312703485 countsByYear W23127034852015 @default.
• W2312703485 countsByYear W23127034852016 @default.
• W2312703485 countsByYear W23127034852017 @default.
• W2312703485 countsByYear W23127034852018 @default.
• W2312703485 countsByYear W23127034852019 @default.
• W2312703485 countsByYear W23127034852020 @default.
• W2312703485 countsByYear W23127034852021 @default.
• W2312703485 countsByYear W23127034852022 @default.
• W2312703485 countsByYear W23127034852023 @default.
• W2312703485 crossrefType "journal-article" @default.
• W2312703485 hasAuthorship W2312703485A5009403725 @default.
• W2312703485 hasAuthorship W2312703485A5022885422 @default.
• W2312703485 hasAuthorship W2312703485A5028164886 @default.
• W2312703485 hasAuthorship W2312703485A5040921984 @default.
• W2312703485 hasAuthorship W2312703485A5052619645 @default.
• W2312703485 hasAuthorship W2312703485A5067054454 @default.
• W2312703485 hasAuthorship W2312703485A5072776358 @default.
• W2312703485 hasAuthorship W2312703485A5080080048 @default.
• W2312703485 hasAuthorship W2312703485A5082310935 @default.
• W2312703485 hasAuthorship W2312703485A5089730795 @default.
• W2312703485 hasBestOaLocation W23127034851 @default.
• W2312703485 hasConcept C126322002 @default.
• W2312703485 hasConcept C126894567 @default.
• W2312703485 hasConcept C141071460 @default.
• W2312703485 hasConcept C2776256026 @default.
• W2312703485 hasConcept C2776694085 @default.
• W2312703485 hasConcept C2778239845 @default.
• W2312703485 hasConcept C2779384505 @default.
• W2312703485 hasConcept C509974204 @default.
• W2312703485 hasConcept C71924100 @default.
• W2312703485 hasConceptScore W2312703485C126322002 @default.
• W2312703485 hasConceptScore W2312703485C126894567 @default.
• W2312703485 hasConceptScore W2312703485C141071460 @default.
• W2312703485 hasConceptScore W2312703485C2776256026 @default.
• W2312703485 hasConceptScore W2312703485C2776694085 @default.
• W2312703485 hasConceptScore W2312703485C2778239845 @default.
• W2312703485 hasConceptScore W2312703485C2779384505 @default.
• W2312703485 hasConceptScore W2312703485C509974204 @default.
• W2312703485 hasConceptScore W2312703485C71924100 @default.
• W2312703485 hasIssue "8" @default.
• W2312703485 hasLocation W23127034851 @default.
• W2312703485 hasLocation W23127034852 @default.
• W2312703485 hasOpenAccess W2312703485 @default.

• next